Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
6.11
+0.03 (0.49%)
Nov 21, 2024, 1:59 PM EST - Market open
Larimar Therapeutics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for LRMR stock have an average target of 19.63, with a low estimate of 14 and a high estimate of 26. The average target predicts an increase of 221.28% from the current stock price of 6.11.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for LRMR stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 3 | 3 |
| Buy | 2 | 2 | 2 | 3 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 5 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +145.50% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +145.50% | Oct 31, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $26 | Buy | Initiates | $26 | +325.53% | Oct 16, 2024 |
| Wedbush | Wedbush | Buy Initiates $22 | Buy | Initiates | $22 | +260.07% | Oct 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +145.50% | Oct 2, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.19
from -0.84
EPS Next Year
-1.58
from -1.19
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 45.9M | ||
| Avg | n/a | n/a | 14.0M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.17 | -1.20 | -0.95 | ||
| Avg | -1.19 | -1.58 | -1.98 | ||
| Low | -1.25 | -2.03 | -2.78 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.